EquBot is an AI investment and wealth management technology company that builds on IBM Watson. It serves institutional and professional investors, not individual retail traders. Its advisory and non-advisory offerings are kept separate, and the non-advisory institutional products sit in a dedicated offering.
The IBM Watson foundation ties EquBot to established enterprise AI infrastructure rather than an unproven in-house model. Its public profile centers on an exchange-traded AI-driven investment strategy, not on a trading app or signal service. Check equbot.com for the current name and status of the related ETF strategy.
EquBot suits asset managers, advisors and institutions that want AI-driven investment technology and can evaluate a strategy on its methodology and risk. It is a poor fit if you want a self-serve app with published prices. Pricing and fee structures are not disclosed publicly, so confirm terms directly with the firm. Like any investment strategy, AI-driven approaches carry market risk, and nothing here is investment advice.











